نتایج جستجو برای: cell immunoglobulin and mucin domain 3

تعداد نتایج: 17429144  

2015
Binh L. Phong Lyndsay Avery Tina L. Sumpter Jacob V. Gorman Simon C. Watkins John D. Colgan Lawrence P. Kane

T cell (or transmembrane) immunoglobulin and mucin domain protein 3 (Tim-3) has attracted significant attention as a novel immune checkpoint receptor (ICR) on chronically stimulated, often dysfunctional, T cells. Antibodies to Tim-3 can enhance antiviral and antitumor immune responses. Tim-3 is also constitutively expressed by mast cells, NK cells and specific subsets of macrophages and dendrit...

Journal: :Nature communications 2015
Chen Zhu Kaori Sakuishi Sheng Xiao Zhiyi Sun Sarah Zaghouani Guangxiang Gu Chao Wang Dewar J Tan Chuan Wu Manu Rangachari Thomas Pertel Hyun-Tak Jin Rafi Ahmed Ana C Anderson Vijay K Kuchroo

The inhibitory receptor T-cell immunoglobulin and mucin domain-3 (Tim-3) has emerged as a critical regulator of the T-cell dysfunction that develops in chronic viral infections and cancers. However, little is known regarding the signalling pathways that drive Tim-3 expression. Here, we demonstrate that interleukin (IL)-27 induces nuclear factor, interleukin 3 regulated (NFIL3), which promotes p...

2017
Ming-Ke Qiu Song-Cun Wang Yong Tang Chang Pan Yang Wang Shu-Qing Wang Zhi-Wei Quan Jing-Min Ou

Endothelial injury and dysfunction followed by endothelial activation and inflammatory cell recruitment are factors contributing to the initiation and progression of atherosclerosis. Oxidized low-density lipoprotein (ox-LDL) promotes inflammation during atherogenesis and lipid deposition in the arterial wall. We observed that stimulation of human umbilical vein endothelial cells (HUVECs) with o...

2013
Niklas Muenchmeier Sophia Boecker Lorenz Bankel Laura Hinz Nicole Rieth Constantin Lapa Anna N. Mendler Elfriede Noessner Ralph Mocikat Peter J. Nelson

BACKGROUND Cellular therapy is a promising therapeutic strategy for malignant diseases. The efficacy of this therapy can be limited by poor infiltration of the tumor by immune effector cells. In particular, NK cell infiltration is often reduced relative to T cells. A novel class of fusion proteins was designed to enhance the recruitment of specific leukocyte subsets based on their expression of...

2017
Jie Dong Xiao-Fei Yang Lin-Xu Wang Xin Wei An-Hui Wang Chun-Qiu Hao Huan-Jun Shen Chang-Xing Huang Ye Zhang Jian-Qi Lian

T-cell immunoglobulin domain and mucin domain-containing molecule-3 (Tim-3) was up-regulated on viral specific T cells and contributed to T cells exhaustion during chronic hepatitis B virus (HBV) infection. However, modulation of Tim-3 expression was still not fully elucidated. To evaluate the potential viral and inflammatory factors involved in the inductor of Tim-3 expression on T cells, 76 p...

Journal: :Cancer immunology research 2014
Ines Pires da Silva Anne Gallois Sonia Jimenez-Baranda Shaukat Khan Ana C Anderson Vijay K Kuchroo Iman Osman Nina Bhardwaj

The immunoregulatory protein T-cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates T-cell exhaustion and contributes to the suppression of immune responses in both viral infections and tumors. Tim-3 blockade reverses the exhausted phenotype of CD4+ and CD8+ T cells in several chronic diseases, including melanoma. Interestingly, natural killer (NK) cells constitutively e...

2014
Hongyan Hou Weiyong Liu Shiji Wu Yanjun Lu Jing Peng Yaowu Zhu Yanfang Lu Feng Wang Ziyong Sun Laurel L. Lenz

Sepsis is an exaggerated inflammatory condition response to different microorganisms with high mortality rates and extremely poor prognosis. Natural killer (NK) cells have been reported to be the major producers of IFN-γ and key players in promoting systematic inflammation in lipopolysaccharide (LPS)-induced endotoxic shock. T-cell immunoglobulin and mucin domain (Tim)-3 pathway has been demons...

Abbas Behzad-Behbahani Alamtaj Samsami Amin Ramezani Farzaneh Aboualizadeh Leili Moezzi Masooma Abdullahi Reza Ranjbaran Sedigheh Sharifzadeh, Zeinab Keshavarz

Objective Maternal-fetal RhD antigen incompatibility causes approximately 50% of clinically significant alloimmunization cases. The routine use of prophylactic anti-D immunoglobulin has dramatically reduced hemolytic disease of the fetus and newborn. Recently, fetal RHD genotyping in RhD negative pregnant women has been suggested for appropriate use of anti-D immunoglobulin antenatal prophylaxi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید